Agnes Le Saux-Narjoz has extensive experience in establishing commercial relationships and managing operations throughout the world. Ms. Le Saux-Narjoz was previously Vice President, Marketing and Commercial Development of Genset, an organization that she joined at its inception in 1989. She was initially responsible for developing and managing. the marketing, sales and distribution activities of Genset's Oligonucleotide Division worldwide. Subsequently her responsibilities broadened to include creating corporate marketing strategies and the identification and establishment of collaborative research and licensing agreements with pharmaceutical and biotechnology partners. Ms. Le Saux-Narjoz also spearheaded the creation and early development of Genset's subsidiaries in Japan, Australia and Singapore. Before joining Genset, Ms. Le Saux-Narjoz held a variety of marketing and strategic planning positions within the biotechnology and pharmaceutical sector most recently at Transgene. Ms. Le Saux-Narjoz is a Director of EGeen Inc., a Biobank's portfolio company. She received her MS in Pharmaceutical Sciences from the University of Paris.
